Wockhardt Limited (NSE:WOCKPHARMA)
1,418.50
+18.90 (1.35%)
Oct 10, 2025, 3:29 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 230.50 billion as of October 10, 2025. Its market cap has increased by 49.06% in one year.
Market Cap
230.50B
Enterprise Value
248.53B
Revenue
30.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,418.50
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 230.50B, an increase of 1,224.40%. That is a compound annual growth rate of 11.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 230.50B | 0.13% |
Dec 31, 2024 | 230.20B | 276.45% |
Dec 29, 2023 | 61.15B | 90.30% |
Dec 30, 2022 | 32.13B | -29.77% |
Dec 31, 2021 | 45.75B | -24.44% |
Dec 31, 2020 | 60.55B | 133.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,979.30B |
Divi's Laboratories | 1,624.80B |
Cipla | 1,207.29B |
Apollo Hospitals Enterprise | 1,101.68B |
Mankind Pharma | 1,013.28B |
Zydus Lifesciences | 1,000.65B |
Fortis Healthcare | 796.75B |
Alkem Laboratories | 656.83B |